Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,693
Closed -$292K 246
2022
Q1
$292K Sell
1,693
-1,244
-42% -$186K 0.11% 250
2021
Q4
$475K Sell
2,937
-1,799
-38% -$289K 0.15% 228
2021
Q3
$706K Sell
4,736
-1,414
-23% -$294K 0.24% 195
2021
Q2
$1.51M Sell
6,150
-461
-7% -$121K 0.44% 127
2021
Q1
$1.75M Buy
6,611
+633
+11% +$179K 0.49% 90
2020
Q4
$1.75M Buy
5,978
+2,610
+77% +$669K 0.52% 46
2020
Q3
$796K Buy
3,368
+2,281
+210% +$519K 0.33% 144
2020
Q2
$216K Buy
1,087
+446
+70% +$83.2K 0.12% 256
2020
Q1
$118K Buy
+641
New +$114K 0.03% 307

Other funds holding AMED

Fort LP's AMED Position: Q2 2022 in Review

Fort LP sold out of Amedisys (AMED) in Q2 2022, closing a stake of 1,693 shares — an estimated $292K sold.

Fort LP first reported a position in AMED in Q1 2020 and held it in 9 quarters. The position peaked at $1.75M in Q4 2020. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2022.

  • Fort LP reported no remaining Amedisys position as of Q2 2022 after selling out during the quarter.
  • Fort LP sold 1,693 Amedisys shares in Q2 2022, an estimated $292K.
  • Fort LP first reported a position in Amedisys in Q1 2020 and held it in 9 quarters.
  • Fort LP's Amedisys position peaked at $1.75M in Q4 2020.
  • 288 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.

Based on Fort LP's 13F filing for Q2 2022, filed 12 Aug 2022.